thymopentin has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chianelli, M; Cruciani, L; Pagani, S; Pozzilli, P; Procaccini, E | 1 |
1 other study(ies) available for thymopentin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Thymopentin administration and increase of sero-conversion after B-hepatitis vaccine in diabetic patients.
Topics: Adjuvants, Immunologic; Adult; Antibody Formation; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Hepatitis B Antibodies; Hepatitis B Vaccines; Humans; Male; Middle Aged; Peptide Fragments; Thymopentin; Thymopoietins; Thymus Hormones; Viral Hepatitis Vaccines | 1989 |